🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Vaccine Prophylaxis

RSV Vaccination in Immunocompromised Patients. NCT06597916Phase 21 site📍 Vienna Medical University of Vienna · Tests: Arexvy powder and suspension for injection Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France NCT06881953n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Questionnaire Real World Evidence Study of SYN023 in Children Exposed to Rabies NCT07327307n/a6 sites📍 Beijing📍 Shenzhen📍 Shenzhen Synermore Biologics (Suzhou) Co., Ltd. Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years NCT06029933n/a1 site📍 Oakland Kaiser Permanente · Tests: Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4), High-Dose Quadrivalent Inactivated Influenza Vaccine (HD… Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases NCT07252804Phase 42 sites📍 São Paulo📍 São Paulo University of Sao Paulo General Hospital · Tests: Meningococcal B (Bexsero) BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants NCT06741072Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Dulbecco''s Phosphate-Buffered Saline, Peptide Vaccine, QS21 Screening Volunteers for Clinical Trials NCT01375530n/a4 sites📍 Atlanta📍 Baltimore📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… PCOM2 - The Physician Communication Intervention, Version 2.0 NCT05336240NA2 sites📍 Aurora📍 Wichita University of Colorado, Denver · Tests: Physician Communication 2 Virtual (PCOM2-virtual), Physician Communication Standard (PCOM-standard) Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ NCT06218303Phase 11 site📍 Pittsburgh Finn, Olivera, PhD · Tests: MUC1 Peptide Vaccine, Hiltonol®, Aromatase Inhibitor, Selective estrogen receptor modulator (SERM) Testing RG1-VLP Vaccine to Prevent HPV-related Cancers NCT05985681Phase 11 site📍 Madison National Cancer Institute (NCI) · Tests: Biospecimen Collection, HPV16 RG1 VLP Vaccine, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalen… An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults NCT07467707Phase 33 sites📍 Cebu City📍 Kamphaeng Phet📍 Hat Yai Bavarian Nordic · Tests: CHIKV VLP vaccine, Placebo Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP) NCT07721649NA2 sites📍 Cologne📍 Hamburg Stephan Baldus · Tests: Intrahospital seasonal influenza vaccination offer, Standardized active influenza vaccination counseling, Standard of c… AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980) NCT07158905Phase 16 sites📍 Boca Raton📍 Miami Lakes📍 Stuart Institute for Molecular Medicine · Tests: AV-1980R 20 µg, AV-1980R 60 µg, AV-1980R 180 µg, Placebo rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older NCT07762014Phase 21 site📍 Athens Biothervax SpA · Tests: Vaccination with rBCG-N-RSV, Vaccination with conventional BCG (BCG-WT) A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant NCT07020533Phase 13 sites📍 Duarte📍 Atlanta📍 Boston City of Hope Medical Center · Tests: Biospecimen Collection, Electronic Health Record Review, Haploidentical Hematopoietic Cell Transplantation, Letermovir,… Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine NCT06885853n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris Factors Affecting Vaccine Prophylaxis Efficacy in Bone Marrow and Solid Organ Transplant Recipients: Impact on Infection and Mortality Rates NCT07473999n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: vaccine prophylaxis Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer NCT06441110Phase 31 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Tislelizumab in Combination with Bacillus Calmette-Guérin Integration to Improve Adolescent Health and HPV Vaccination in Laos NCT06650956NA1 site📍 Muang Sing Health Poverty Action · Tests: Integrated HPV and SRH Service Package, Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health NCT07565090Phase 13 sites📍 Washington D.C.📍 Lenexa📍 Boston International AIDS Vaccine Initiative · Tests: rVSVΔG-SUDV-GP, Placebo XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia NCT06980155EARLY Phase 11 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Personalized neoantigen tumor vaccine, PD-1 inhibitor Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases NCT07087912Phase 42 sites📍 São Paulo📍 São Paulo University of Sao Paulo General Hospital · Tests: Dengue 1,2,3,4 (attenuated) vaccine Real-world Effectiveness, Safety & Immunogenicity of Chikungunya Vaccination: Ambispective Study in Reunion & French Guiana NCT06928753Phase 42 sites📍 Cayenne📍 Saint-Denis Centre Hospitalier Universitaire de la Réunion · Tests: IXCHIQ, VIMKUNYA Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC NCT06341907Phase 2, Phase 31 site📍 Wenzhou Second Affiliated Hospital of Wenzhou Medical University · Tests: Neoantigen polypeptide vaccine ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention NCT06535139NA1 site📍 Gainesville University of Florida · Tests: Brief training, Parent-targeted motivational aids, Healthcare access Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever NCT06799013Phase 11 site📍 San Antonio HDT Bio · Tests: 10 ug HDT 321, 25ug HDT-321, 50ug HDT-321 Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients NCT07195032Phase 41 site📍 Kansas City Children's Mercy Hospital Kansas City · Tests: Commercial measles, mumps, and rubella (MMR) vaccine HPV Vaccine Reduced Dose NCT06799494Phase 41 site📍 Decatur Emory University · Tests: Gardasil-9, Lidocaine injection, Lorazepam A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant NCT04006808Phase 1, Phase 231 sites📍 Brussels📍 Ghent📍 Leuven GlaxoSmithKline · Tests: PED-HZ/su Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad NCT07038837Phase 41 site📍 Moïssala Epicentre · Tests: "Synchronised" arm (intervention)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy